The effect of freeze-dryiny with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles

被引:80
作者
Bozdag, S
Dillen, K
Vandervoort, J
Ludwig, A
机构
[1] Univ Instelling Antwerp, Dept Pharmaceut Sci, Lab Pharmaceut Technol & Biopharm, B-2610 Antwerp, Belgium
[2] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
关键词
D O I
10.1211/0022357056145
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, the influence of freeze-drying with several cryoprotective agents and gamma (gamma)-irradiation sterilization on the physicochemical characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles was evaluated. Nanoparticles were prepared by W/O/W emulsification solvent evaporation followed by high-pressure homogenization. They were freeze-dried in the presence of 5.0% (w/v) mannitol, trehalose or glucose, with 5.0% (w/v) or 15.0% (w/v) dextran as cryoprotectants. The nanoparticles were irradiated at a dose of 25 kGy using a (CO)-C-60 source. The following physicochemical properties of the formulations were investigated: the ratio of particle size before (initial) and after freeze-drying, the ease of reconstitution of the nanoparticle suspensions and the drug-release profiles of irradiated and non-irradiated nanoparticles. The antibacterial activity against Pseudomonas aeruginosa was measured. The freeze-drying process induced a significant increase in particle size when no cryoprotectant was employed. Similar results were observed when cryoprotectants were added to the formulation. Only when mannitol was used was no significant size increase measured. Moreover, for formulations with dextran, reconstitution after freeze-drying was difficult by manual agitation and particle size could not be determined because of aggregation. After gamma-sterilization no significant difference in mean particle size was observed, but reconstitution was more difficult and drug release was influenced negatively. Ciprofloxacin HCl incorporated in the nanoparticles was still effective against the micro-organism selected after freeze-drying and gamma-sterilization.
引用
收藏
页码:699 / 707
页数:9
相关论文
共 33 条
[1]  
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
[2]   Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery [J].
Barbault-Foucher, S ;
Gref, R ;
Russo, P ;
Guechot, J ;
Bochot, A .
JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) :365-375
[3]   Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique:: influence of γ-irradiation on radical formation and polymer degradation [J].
Bittner, B ;
Mäder, K ;
Kroll, C ;
Borchert, HH ;
Kissel, T .
JOURNAL OF CONTROLLED RELEASE, 1999, 59 (01) :23-32
[4]   Influence of irradiation sterilization on poly(lactide-co-glycolide) microspheres containing anti-inflammatory drugs [J].
Çalis, S ;
Bozdag, S ;
Kas, HS ;
Tunçay, M ;
Hincal, AA .
FARMACO, 2002, 57 (01) :55-62
[5]   Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers [J].
Chacón, M ;
Molpeceres, J ;
Berges, L ;
Guzmán, M ;
Aberturas, MR .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 8 (02) :99-107
[6]  
*COUNC EUR, 1997, EUR PHARM, P637
[7]   Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles:: Influence on physical stability and in vitro cell uptake [J].
De Jaeghere, F ;
Allémann, E ;
Leroux, JC ;
Stevels, W ;
Feijen, J ;
Doelker, E ;
Gurny, R .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :859-866
[8]   Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles [J].
Dillen, K ;
Vandervoort, J ;
Van den Mooter, G ;
Verheyden, L ;
Ludwig, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 275 (1-2) :171-187
[9]   Recent developments in ophthalmic drug delivery [J].
Ding, SL .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (08) :328-335
[10]   Freeze-drying of bioproducts: putting principles into practice [J].
Franks, F .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :221-229